Align Technology price target raised to $195 from $185 at BofA

BofA raised the firm’s price target on Align Technology (ALGN) to $195 from $185 and keeps an Underperform rating on the shares. Q1 sales of $979.3M were above BofA and Street estimates while adjusted EPS of $2.13 was also above expectations, the analyst tells investors. Despite the “solid quarter,” external pressures persist and with consumer sentiment remaining poor, and with no change to the FY25 volume guidance, it is “difficult to translate the 1Q beat to a more optimistic outlook on the rest of the year,” the analyst added.